|
|
Profile of vemurafenib-induced severe skin toxicities
Lucie Peuvrel
,
Gaelle Quéreux
,
Mélanie Saint-Jean
,
A. Brocard
,
Jean Michel Nguyen
,
et al.
Journal of the European Academy of Dermatology and Venereology, 2016, 30 (2), pp.250 - 257. ⟨10.1111/jdv.13443⟩
Journal articles
inserm-01819814v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Clinical significance of BRAF mutation status in circulating tumor DNA of metastatic melanoma patients at baseline
Anne C Knol
,
Audrey Vallée
,
Guillaume Herbreteau
,
Jean-Michel C Nguyen
,
Emilie Varey
,
et al.
Journal articles
inserm-01408920v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficient Detection of BRAF Mutation in Plasma of Patients after Long-term Storage of Blood in Cell-Free DNA Blood Collection Tubes
Marc G. Denis
,
Anne-Chantal Knol
,
Sandrine Théoleyre
,
Audrey Vallée
,
Brigitte Dréno
Journal articles
inserm-01820298v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Targeting CD8 T-Cell Metabolism in Transplantation
Michelle Yap
,
Sophie Brouard
,
Claire Pecqueur
,
Nicolas Degauque
Journal articles
inserm-02147167v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Comparative analysis of BRAF, NRAS and c-KIT mutation status between tumor tissues and autologous tumor cell-lines of stage III/IV melanoma
Anne-Chantal Knol
,
Marie-Christine Pandolfino
,
Audrey Vallée
,
Frédérique Nguyen
,
Virginie Lella
,
et al.
Journal articles
inserm-01818897v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients
E. Dugast
,
J.-P. Soulillou
,
Y. Foucher
,
E. Papuchon
,
P. Guerif
,
et al.
Journal articles
inserm-02150143v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
T-cell therapy using a bank of EBV-specific cytotoxic T cells: lessons from a phase I/II feasibility and safety study.
Géraldine Gallot
,
Solène Vollant
,
Soraya Saïagh
,
Béatrice Clémenceau
,
Régine Vivien
,
et al.
Journal articles
hal-01256575v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|